{"id":45437,"date":"2023-11-20T05:13:20","date_gmt":"2023-11-20T11:13:20","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/aren0532-pub\/"},"modified":"2023-11-20T05:13:20","modified_gmt":"2023-11-20T11:13:20","slug":"aren0532-pub","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/aren0532-pub\/","title":{"rendered":"AREN0532-PUB"},"template":"","class_list":["post-45437","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p><span><span>Fernandez, C. V., Mullen, E. A., Chi, Y.-Y., Ehrlich, P. F., Perlman, E. J., Kalapurakal, J. A., Khanna, G., Paulino, A. C., Hamilton, T. E., Gow, K. W., Tochner, Z., Hoffer, F. A., Withycombe, J. S., Shamberger, R. C., Kim, Y., Geller, J. I., Anderson, J. R., Grundy, P. E., &amp; Dome, J. S. (2018). Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children\u2019s Oncology Group Study AREN0532. In Journal of Clinical Oncology (Vol. 36, Issue 3, pp. 254\u2013261). American Society of Clinical Oncology (ASCO)<\/span>. <a href=\"https:\/\/doi.org\/10.1200\/jco.2017.73.7999\">https:\/\/doi.org\/10.1200\/jco.2017.73.7999<\/a><\/span><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.1200\/jco.2017.73.7999","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/45437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=45437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}